Alaunos Therapeutics | ZIOP - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Baxter International USD 3.69B 723M 2026-03
Biogen USD 3B 350.5M 2026-03
Bioline Rx USD 13.62M 1.5M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Celltrion KRW 292.71B 9.09B 2026-03
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Curis USD 14.08M 5.3M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Incyte USD 1.49B 25.52M 2026-03
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 717M 66M 2026-03
J&J USD 54.9B 2.82B 2026-06
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Merck USD 26.94B 1.38B 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 186K 2.26M 2025-06
Pfizer USD 34.35B 2.64B 2026-03
Pharma Mar EUR 89.23M 4.65M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Qiagen NV USD 479.11M 33.03M 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
TG Therapeutics USD 187.11M 33.35M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Verastem USD 72.27M 12.56M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03